159 related articles for article (PubMed ID: 36164837)
1. Topical treatments for erythromelalgia.
Raef HS; Williams M; Fedeles F
Dermatol Ther; 2022 Nov; 35(11):e15860. PubMed ID: 36164837
[TBL] [Abstract][Full Text] [Related]
2. Primary erythromelalgia: a review.
Tang Z; Chen Z; Tang B; Jiang H
Orphanet J Rare Dis; 2015 Sep; 10():127. PubMed ID: 26419464
[TBL] [Abstract][Full Text] [Related]
3. Primary erythromelalgia in a 12-year-old boy: positive response to sodium channel blockers despite negative SCN9A mutations.
Jakob A; Creutzfeldt R; Staszewski O; Winterpacht A; Berner R; Hufnagel M
Klin Padiatr; 2012 Sep; 224(5):309-12. PubMed ID: 22170168
[TBL] [Abstract][Full Text] [Related]
4. Pediatric Erythromelalgia and SCN9A Mutations: Systematic Review and Single-Center Case Series.
Arthur L; Keen K; Verriotis M; Peters J; Kelly A; Howard RF; Dib-Hajj SD; Waxman SG; Walker SM
J Pediatr; 2019 Mar; 206():217-224.e9. PubMed ID: 30416015
[TBL] [Abstract][Full Text] [Related]
5. A Novel SCN9A Mutation (F826Y) in Primary Erythromelalgia Alters the Excitability of Nav1.7.
Wu B; Zhang Y; Tang H; Yang M; Long H; Shi G; Tang J; Shi X
Curr Mol Med; 2017; 17(6):450-457. PubMed ID: 28990532
[TBL] [Abstract][Full Text] [Related]
6. [Erythromelalgia: Diagnosis and therapeutic approach].
Miranda S; Le Besnerais M; Langlois V; Benhamou Y; Lévesque H
Rev Med Interne; 2017 Mar; 38(3):176-180. PubMed ID: 27639908
[TBL] [Abstract][Full Text] [Related]
7. Life-threatening hypothermia in a child with primary erythromelalgia.
Matarneh B; Witman P
Pediatr Dermatol; 2022 Jan; 39(1):135-136. PubMed ID: 34888934
[TBL] [Abstract][Full Text] [Related]
8. Nav1.7-A1632G Mutation from a Family with Inherited Erythromelalgia: Enhanced Firing of Dorsal Root Ganglia Neurons Evoked by Thermal Stimuli.
Yang Y; Huang J; Mis MA; Estacion M; Macala L; Shah P; Schulman BR; Horton DB; Dib-Hajj SD; Waxman SG
J Neurosci; 2016 Jul; 36(28):7511-22. PubMed ID: 27413160
[TBL] [Abstract][Full Text] [Related]
9. [Erythromelalgia: skin redness and pain].
Dusch M; Schmelz M
Schmerz; 2019 Oct; 33(5):475-490. PubMed ID: 31485751
[TBL] [Abstract][Full Text] [Related]
10. Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.
Natkunarajah J; Atherton D; Elmslie F; Mansour S; Mortimer P
Clin Exp Dermatol; 2009 Dec; 34(8):e640-2. PubMed ID: 19549232
[TBL] [Abstract][Full Text] [Related]
11. An atypical case of SCN9A mutation presenting with global motor delay and a severe pain disorder.
Meijer IA; Vanasse M; Nizard S; Robitaille Y; Rossignol E
Muscle Nerve; 2014 Jan; 49(1):134-8. PubMed ID: 23893323
[TBL] [Abstract][Full Text] [Related]
12. Erythromelalgia caused by the missense mutation p.Arg220Pro in an alternatively spliced exon of SCN9A (NaV1.7).
Deuis JR; Kumble S; Keramidas A; Ragnarsson L; Simons C; Pais L; White SM; Vetter I
Hum Mol Genet; 2024 Jan; 33(2):103-109. PubMed ID: 37721535
[TBL] [Abstract][Full Text] [Related]
13. Secondary erythromelalgia successfully treated with intravenous immunoglobulin.
Moody S; Pacheco S; Butler IJ; Koenig MK
J Child Neurol; 2012 Jul; 27(7):922-3. PubMed ID: 22156790
[TBL] [Abstract][Full Text] [Related]
14. [Neuropathic pain associated with Nav1.7 mutations: clinical picture and treatment].
Doppler K; Sommer C
Nervenarzt; 2013 Dec; 84(12):1428-35. PubMed ID: 24202110
[TBL] [Abstract][Full Text] [Related]
15. A severe case of primary erythromelalgia presenting as small fiber neuropathy with a novel SCN9A mutation.
Watabe D; Tominaga M; Toyama S; Takamori K; Nakano H; Amano H
J Dermatol; 2023 Jul; 50(7):938-941. PubMed ID: 36815391
[TBL] [Abstract][Full Text] [Related]
16. A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity.
Sheets PL; Jackson JO; Waxman SG; Dib-Hajj SD; Cummins TR
J Physiol; 2007 Jun; 581(Pt 3):1019-31. PubMed ID: 17430993
[TBL] [Abstract][Full Text] [Related]
17. Gain-of-function mutation of a voltage-gated sodium channel Na
Tanaka BS; Nguyen PT; Zhou EY; Yang Y; Yarov-Yarovoy V; Dib-Hajj SD; Waxman SG
J Biol Chem; 2017 Jun; 292(22):9262-9272. PubMed ID: 28381558
[TBL] [Abstract][Full Text] [Related]
18. Paediatric hypertension-associated erythromelalgia responds to corticosteroids and is not associated with SCN9A mutations.
Morales PS; Escobar RG; Lizama M; Aglony M; Salomon J; Drenth JP; Borzutzky A
Rheumatology (Oxford); 2012 Dec; 51(12):2295-6. PubMed ID: 22718865
[No Abstract] [Full Text] [Related]
19. Inherited erythromelalgia due to mutations in SCN9A: natural history, clinical phenotype and somatosensory profile.
McDonnell A; Schulman B; Ali Z; Dib-Hajj SD; Brock F; Cobain S; Mainka T; Vollert J; Tarabar S; Waxman SG
Brain; 2016 Apr; 139(Pt 4):1052-65. PubMed ID: 26920677
[TBL] [Abstract][Full Text] [Related]
20. Review of primary and secondary erythromelalgia.
Mann N; King T; Murphy R
Clin Exp Dermatol; 2019 Jul; 44(5):477-482. PubMed ID: 30609105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
